The forecast for diuretic medicine sales in Canada shows a consistent upward trend from 2024 to 2028, with values rising steadily from 8.1 to 9.2 USD PPP per capita. This represents a year-on-year growth of approximately 2.5% over the period, suggesting a stable increase in demand or price adjustment for these medicines. Recorded data from 2023 places these figures in context, highlighting a continued growth pattern in this sector.

Future trends to watch include:

Potential impact of healthcare policies in Canada that could influence medicine pricing or accessibility.
Innovation in diuretic medicines that may affect availability and sales.
Changing demographics that could alter the demand, such as an aging population increasing consumption.